Stability and expression of SARS-CoV-2 spike-protein mutations

被引:8
|
作者
Baek, Kristoffer T. [1 ]
Mehra, Rukmankesh [2 ]
Kepp, Kasper P. [1 ]
机构
[1] Tech Univ Denmark, DTU Chem, Bldg 206, DK-2800 Lyngby, Denmark
[2] Indian Inst Technol Bhilai, Dept Chem, Raipur 492015, Chhattisgarh, India
关键词
SARS-CoV-2; COVID-19; Spike-protein; Mutations; Protein stability; RECEPTOR-BINDING DOMAIN; CRYO-EM; TEMPERATURE; EVOLUTION; SEQUENCE; CONSTRAINTS; RESOLUTION; EPISTASIS;
D O I
10.1007/s11010-022-04588-w
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Protein fold stability likely plays a role in SARS-CoV-2 S-protein evolution, together with ACE2 binding and antibody evasion. While few thermodynamic stability data are available for S-protein mutants, many systematic experimental data exist for their expression. In this paper, we explore whether such expression levels relate to the thermodynamic stability of the mutants. We studied mutation-induced SARS-CoV-2 S-protein fold stability, as computed by three very distinct methods and eight different protein structures to account for method- and structure-dependencies. For all methods and structures used (24 comparisons), computed stability changes correlate significantly (99% confidence level) with experimental yeast expression from the literature, such that higher expression is associated with relatively higher fold stability. Also significant, albeit weaker, correlations were seen between stability and ACE2 binding effects. The effect of thermodynamic fold stability may be direct or a correlate of amino acid or site properties, notably the solvent exposure of the site. Correlation between computed stability and experimental expression and ACE2 binding suggests that functional properties of the SARS-CoV-2 S-protein mutant space are largely determined by a few simple features, due to underlying correlations. Our study lends promise to the development of computational tools that may ideally aid in understanding and predicting SARS-CoV-2 S-protein evolution.
引用
收藏
页码:1269 / 1280
页数:12
相关论文
共 50 条
  • [41] Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies
    Alenquer, Marta
    Ferreira, Filipe
    Lousa, Diana
    Valerio, Mariana
    Medina-Lopes, Monica
    Bergman, Marie-Louise
    Goncalves, Juliana
    Demengeot, Jocelyne
    Leite, Ricardo B.
    Lilue, Jingtao
    Ning, Zemin
    Penha-Goncalves, Carlos
    Soares, Helena
    Soares, Claudio M.
    Amorim, Maria Joao
    PLOS PATHOGENS, 2021, 17 (08)
  • [42] Conformational variability of loops in the SARS-CoV-2 spike protein
    Wong, Samuel W. K.
    Liu, Zongjun
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2022, 90 (03) : 691 - 703
  • [43] Mutation profile of SARS-CoV-2 spike protein and identification of potential multiple epitopes within spike protein for vaccine development against SARS-CoV-2
    Paul D.
    Pyne N.
    Paul S.
    VirusDisease, 2021, 32 (4) : 703 - 726
  • [44] Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies
    Katharina Müller
    Philipp Girl
    Andreas Giebl
    Stefanie Gruetzner
    Markus Antwerpen
    Elham Khatamzas
    Roman Wölfel
    Heiner von Buttlar
    Virus Genes, 2021, 57 : 502 - 509
  • [45] Characterization of a Novel SARS-CoV-2 Genetic Variant with Distinct Spike Protein Mutations
    Gladkikh, Anna
    Dolgova, Anna
    Dedkov, Vladimir
    Sbarzaglia, Valeriya
    Kanaeva, Olga
    Popova, Anna
    Totolian, Areg
    VIRUSES-BASEL, 2021, 13 (06):
  • [46] Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies
    Mueller, Katharina
    Girl, Philipp
    Giebl, Andreas
    Gruetzner, Stefanie
    Antwerpen, Markus
    Khatamzas, Elham
    Woelfel, Roman
    von Buttlar, Heiner
    VIRUS GENES, 2021, 57 (06) : 502 - 509
  • [47] SARS-CoV-2: phylogenetic status, mutations and therapeutic research based on spike protein
    Zhu, Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (18) : 5843 - 5852
  • [48] Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations
    Tsai, Ming-Shao
    Shih, Wei-Tai
    Yang, Yao-Hsu
    Lin, Yu-Shih
    Chang, Geng-He
    Hsu, Cheng-Ming
    Yeh, Reming-Albert
    Shu, Li-Hsin
    Cheng, Yu-Ching
    Liu, Hung-Te
    Wu, Yu-Huei
    Wu, Yu-Heng
    Shen, Rou-Chen
    Wu, Ching-Yuan
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 149
  • [49] Is the Stalk of the SARS-CoV-2 Spike Protein Druggable?
    Pipito, Ludovico
    Reynolds, Christopher A.
    Deganutti, Giuseppe
    VIRUSES-BASEL, 2022, 14 (12):
  • [50] Proteolytic activation of SARS-CoV-2 spike protein
    Takeda, Makoto
    MICROBIOLOGY AND IMMUNOLOGY, 2022, 66 (01) : 15 - 23